According to AngioDynamics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.725661. At the end of 2024 the company had a P/S ratio of 0.6765.
Year | P/S ratio | Change |
---|---|---|
2024 | 0.6765 | -18.44% |
2023 | 0.8295 | -42.99% |
2022 | 1.45 | -56.16% |
2021 | 3.32 | 65.05% |
2020 | 2.01 | -27.32% |
2019 | 2.77 | 5.06% |
2018 | 2.63 | 42.33% |
2017 | 1.85 | 11.35% |
2016 | 1.66 | 35.41% |
2015 | 1.23 | -28.87% |
2014 | 1.72 | 8.89% |
2013 | 1.58 | 20.68% |
2012 | 1.31 | -22.74% |
2011 | 1.70 | 6.37% |
2010 | 1.60 | -13.91% |
2009 | 1.86 | 15.07% |
2008 | 1.61 | -49.43% |
2007 | 3.19 | -14.51% |
2006 | 3.73 | -0.06% |
2005 | 3.73 | 10% |
2004 | 3.39 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.85 | 430.24% | ๐บ๐ธ USA |
Boston Scientific BSX | 7.56 | 942.10% | ๐บ๐ธ USA |
Teleflex TFX | 3.27 | 351.07% | ๐บ๐ธ USA |
Merit Medical MMSI | 3.39 | 366.98% | ๐บ๐ธ USA |
LeMaitre Vascular LMAT | 7.31 | 907.00% | ๐บ๐ธ USA |
ICU Medical
ICUI | 1.04 | 43.75% | ๐บ๐ธ USA |